Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer.
Study design not specified in the source record · Prostate Cancer Prostatic Dis · 2018. Source record refreshed; an explanation has not been reviewed.
About this paper
This page identifies the publication and its source. A checked explanation of its findings is not yet available.
Reading this record
Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.
Publication details
Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer.
Giridhar KV, Sanhueza C, Hillman DW et al.
Prostate Cancer Prostatic Dis · 2018
- PubMed ID
- 29858590
- Record checked
A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.
Keep your place in the research.
Save this source or mark it as read.